The Ministry of Ayush has formed an Inter-disciplinary Ayush R&D Task Force having representation from Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), All India Institute of Medical Sciences (AIIMS) and Ayush Institutions. The Inter-disciplinary Ayush R&D Task Force has developed and designed clinical research protocols for prophylactic studies and add-on interventions in Covid 19 positive cases through thorough review and consultative process of high repute experts from various organizations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi + Pippali and a poly herbal formulation (AYUSH-64). Under various research organizations and National Research Institutes 126 studies are going on in 152 centers in the country to identify effective medicine to cure patients with Covid 19 symptoms.

The Government of India has released “National Clinical Management Protocol based on Ayurveda and Yoga for management of Covid 19” prepared by National Task Force in consensus from various expert committees. Apart from this, varied guidelines and advisories have been issued for management of Covid-19 by Ayurveda, Siddha, Unani and Homoeopathy Practitioners respectively.

Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken four collaborative research studies in COVID-19 in which the Ayurvedic formulations have been administered as add on to conventional standard care. Further four collaborative studies have Ayurvedic formulations as standalone treatment out of which two studies have conventional standard care as control arm and remaining two studies are standalone Ayurveda intervention.

Share this :